Cargando…

Sunitinib-Induced Adrenal Crisis in a Patient with Pre-Existing Immunotherapy-Related Hypopituitarism

Sunitinib is a tyrosine kinase inhibitor that is frequently used in the treatment of metastatic renal cell carcinoma (mRCC). As a multikinase inhibitor, numerous off-target side effects of this medication are widely recognized. More recently, endocrine side effects, including hypoadrenalism, are bec...

Descripción completa

Detalles Bibliográficos
Autores principales: Javaid, Anadil, Mathai, Jared, Song, David, Brown, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832234/
https://www.ncbi.nlm.nih.gov/pubmed/35221962
http://dx.doi.org/10.1159/000521206

Ejemplares similares